Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/27/2000CN1278000A Human glucotranferring protein, and coding series thereof
12/27/2000CN1277999A Human cell periodic protein isomer protein, and coding series thereof
12/27/2000CN1277998A Human nitrile hydrolytic enzyme protein and coding series thereof
12/27/2000CN1277997A Glycoprotein relating to human muscle nutrition and coding series therefor
12/27/2000CN1277996A Novel polypeptide-human galactose transferase 40, and polynucleotide for coading same
12/27/2000CN1277995A Novel polypeptide-human cell pigment oxidase related protein 37, and polynucleotide for coding same
12/27/2000CN1277970A Novel polypeptide-human sarcoma protein 20, and polynucleotide for coding same
12/27/2000CN1059929C Human thymosin alpha-source and preparing method thereof
12/27/2000CN1059928C Method for preparing antigenic protein capable of testing C-type hepatitis by using colibacillus
12/27/2000CN1059927C Reconstituted hepatitis B vaccine with corboxy and having anterior surface antigen 1 determinant
12/27/2000CN1059926C Glucokinase gene and its high expression engineering strain
12/27/2000CN1059923C Detoxicating engineering bacteria and its application
12/26/2000US6166306 Method of producing hybrid catharanthus using male sterility
12/26/2000US6166302 Nucleotide sequence that codes an insecticidal crystal protein; for biological pest control; insecticides
12/26/2000US6166301 Method for assaying genetic attributes in cotton fiber cells
12/26/2000US6166295 Composition and method for plant pathogen resistance
12/26/2000US6166294 Nucleotide sequences which are expressed at preferential time during plant development for more efficient production of plant by-product
12/26/2000US6166293 Method of increasing growth and yield in plants
12/26/2000US6166292 Raffinose synthetase gene, method of producing raffinose and transgenic plant
12/26/2000US6166291 Amplification of disease tolerance to sclerotinia; mating genetically engineered eukaryotic cells coding a preferential oxidase with eukaryotic cells that are disease tolerant, recovering propagants
12/26/2000US6166290 Glutathione-S-conjugate transport in plants
12/26/2000US6166289 IRAK modified transgenic animals
12/26/2000US6166288 Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
12/26/2000US6166287 Screening for modulators useful in the treatment of cushing's syndrome and anxiety; administering modulators to transgenic rodent, monitoring expression of protein in preferential hypothalmus cells, compare to wild-type expression
12/26/2000US6166199 Contacting purine with amino, hydrazine, hydroxylamine, thiol, semicarbazide, thiosemicarbazide, hydrazone, hydrazide, imidazole, tetrazole, triazole, pyrrolidine, piperidine, piperazine, morpholine, aldehyde, ketone, alcohol; antisense
12/26/2000US6166196 Amplification and detection of Campylobacter jejuni and Campylobacter coli
12/26/2000US6166195 Nucleotide sequences that encode a nematocide
12/26/2000US6166194 Nucleotide sequences coding cancer modulator protein; for gene therapy; antitumor agents
12/26/2000US6166193 Nucleotide sequence which encodes g-protein coupled receptor; for the treatment and prevention of bacterial, fungal, protozoan and viral infections; for use in gene therapy
12/26/2000US6166192 PGC-1, a novel brown fat PPARγ coactivator
12/26/2000US6166191 Nucleotide sequences coding cancer protein; for diagnosis and detection of cell proliferative and developmental defects
12/26/2000US6166186 Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma
12/26/2000US6166185 Antibodies to human TIE-2 ligands
12/26/2000US6166182 Polypeptides for the treatment of bacterial, fungal, protozoan and viral infections
12/26/2000US6166181 Mammalian binding protein; for the treatment of cardiovascular, kidney, brain, psychological and nervous system disorders; antihypoxic agents; hypotensive agents; antiischemic agents
12/26/2000US6166180 Polypeptide for the treatment of genetic disorders associated with transmembrane protein
12/26/2000US6166178 Polypeptide for the treatment of cancer; anticarcinogenic agents
12/26/2000US6166176 Cancer marker protein and peptides thereof
12/26/2000US6166049 A treatment and/or prophylaxis of hyperglycaemia, pre-diabetic insulin resistance syndrome by administering an agonist of peroxisome proliferator-activated receptor to stimulate fatty oxidation
12/26/2000US6165992 Histidine kinase
12/26/2000US6165991 A polynucleotide, or the full complement of the entire length of the polynucleotide, which encodes the same mature polypeptide, expressed by histidine kinase encoded by a specific polynucleotide contained in streptococcus pneumoniae
12/26/2000US6165990 Use of antisense gastrin expression to reduce colon cancer growth
12/26/2000US6165989 An isolated polynucleotide comprising a first polynucleotide or the full complement of the entire length of the first polynucleotide, wherein the first polynucleotide encodes a polypeptide comprising specific amino acid sequence
12/26/2000US6165960 Use of alkaline proteases in industrial textile laundering processes
12/26/2000US6165794 Suppression of proteolytic activity by dysfunctional protease formation
12/26/2000US6165793 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
12/26/2000US6165792 Amino acid transporters
12/26/2000US6165791 Nucleotide sequences which prevent the transcription of genes associated with an activator of transcription; for the treatment of cell proliferation defects; antiproliferative agents; anticarcinogenic agents
12/26/2000US6165790 Antisense modulation of PI3 kinase p55 gamma expression
12/26/2000US6165789 Antisense modulation of hnRNP A1 expression
12/26/2000US6165787 Regulated transcription of targeted genes and other biological events
12/26/2000US6165786 Antisense modulation of nucleolin expression
12/26/2000US6165782 Nucleotide sequences for the transfer of heterologous nucleotide sequences to cells and biosynthesis of transcripts and heterologous proteins
12/26/2000US6165781 Nucleotide sequences comprising an inverted terminal duplication and heterologous nucleotide sequences; for the treatment of genetic disorders and gene therapy
12/26/2000US6165780 Plasmid for the efficient transformation of seed plants
12/26/2000US6165779 Recombinant virus vector such as tumor suppressor gene formulated in a buffer comprising a detergent; for gene therapy of cancer; buffer comprising a delivery-enhancing agent
12/26/2000US6165774 Culturing virus in cells, separating out virus, solubilizing hemagglutinin-neuramidase and fusion envelope glycoproteins from virus, and coisolating and copurifying using ion exchange chromatography and hydroxyapatite matrix
12/26/2000US6165772 Simple and cost-effective preparation of vehicle for delivery of dna, rna, protein, peptide nucleic acids, or lipophilic drugs
12/26/2000US6165771 Compounds
12/26/2000US6165767 Protein phosphatase-related molecules
12/26/2000US6165766 Amino acid sequence of serine/threonine protein kinase; anticarcinogenic/antiarthritic/antiinflammatory agents; treatment of osteoporosis, adult respiratory disease syndrome, inflammatory bowel disease, eating disorders; diagnosis
12/26/2000US6165765 Heat resistant enzyme from bacillus; for more accurate sequence determination using chain terminating nucleotides
12/26/2000US6165763 Nucleotide and amino acid sequences of enzyme from streptococcus; for drug screening of bacteriostats and bactericides
12/26/2000US6165762 Amino acid sequence of enzyme; drug screening of bactericides and bacteriostats; vaccines; diagnosis of infections
12/26/2000US6165760 Amino acid sequence of polypeptide of the glutamyl transfer rna synthetase family; drug screening of bacteriostats and bactericides; vaccines; diagnosis of infections
12/26/2000US6165759 Amino acid sequence; diagnosis, prophylaxis and therapy of infections; vaccines; bacteriostats; bactericides; screening of enzyme inhibitors and activators
12/26/2000US6165756 Bacterial strain of Escherichia coli BKIIM B-3996 as the producer of L-threonine
12/26/2000US6165755 Chicken neuropeptide gene useful for improved poultry production
12/26/2000US6165754 Method of expressing an exogenous nucleic acid
12/26/2000US6165753 Cyclin E genes and proteins
12/26/2000US6165752 Expression system which produces polypeptide of defined amino acid sequence when present in a cell; diagnosis and therapy for creutzfeldt-jakob disease and nervous system disorders; anticarcinogenic agents
12/26/2000US6165751 HLDAT86 polynucleotides
12/26/2000US6165750 Streptavidin tetramers have at least one monomer containing an amino acid modification that produces a reduced binding affinity for biotin, a modified off-rate, a modified on-rate, or an altered binding enthalpy; bioseparations, drug delivery
12/26/2000US6165749 Plasmid vector comprising promoter sequence to control expression of desired gene, said promoter sequence being recognized by rna polymerase derived from sp6 phage, and a replication origin for increasing copy number by induction
12/26/2000US6165748 Useful in the modulation of cellular formation, growth, differentiation, proliferation and/or maintenance of a variety of adult and embryonic tissues and organs
12/26/2000US6165747 Comprise morphogenic signals produced by tissue patterning centers, and are involved in the formation of ordered spatial arrangements of differentiated tissues in vertebrates
12/26/2000US6165746 Preventing endogenous aminopeptidase mediated n-terminal amino acid cleavage during expression of foreign genes in bacteria
12/26/2000US6165744 Isolation and characterization of cDNAs coding for the α, β, and γ subunits of the high-affinity receptor for immunoglobulin E
12/26/2000US6165738 Hybrid of two human isoforms; for recombinant production; for diagnosis, presymptomatic detection, and prevention of insulin dependent diabetes mellitus
12/26/2000US6165737 Screening modulators of human dff40 activity by contacting cell expressing recombinant, human dff40/dff45 complex with candidate; activating factor; and comparing apoptosis with or without candidate
12/26/2000US6165735 Parasitic helminth asparaginase proteins, nucleic acid molecules, and uses thereof
12/26/2000US6165733 γ II adaptin
12/26/2000US6165728 Nucleotide sequences which hybridize to gene and inhibit gene expression of human adaptor protein involved in signal transduction; diagnosis, therapy, and prophylaxis of related diseases
12/26/2000US6165727 Analyzing the dna sequence of angiotensinogen gene for a mutation which is in linkage disequilibrium with mutation m235t; presence indicates predisposition
12/26/2000US6165724 Oligonucleotides for detecting enteric hemorrhagic E.coli and detection method using the same
12/26/2000US6165722 Representations of bimolecular interactions
12/26/2000US6165721 Oligonucleotides of specific nucleotide sequences; for strand displacement amplification; for hybridization probes
12/26/2000US6165720 Conjugating nucleic acid with a peptide nucleic acid in a sequence-specific manner prior to transfection, transfecting cell with conjugate, and monitoring intracellular location
12/26/2000US6165719 hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
12/26/2000US6165718 Method for in vivo production of a mutant library in cells
12/26/2000US6165717 Method of synthesizing diverse collections of oligomers
12/26/2000US6165716 Diagnosis of migraine, bipolar disorder, unipolar depression, or susceptibility in human by sampling nucleic acids and analyzing number of copies of variable number tandem repeat region in the second intron of serotonin transporter gene
12/26/2000US6165715 Expression systems
12/26/2000US6165714 Devices and methods for detecting nucleic acid analytes in samples
12/26/2000US6165713 Composition and methods relating to DNA mismatch repair genes
12/26/2000US6165712 Contacting a cell with an exogenous molecule effective to modulate gene expression and affect level of protein thus pathological effect; molecule binds to regulatory sequence, rna, or transcription regulating protein; viricides
12/26/2000US6165711 Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
12/26/2000US6165709 Rapid and less expensive method by identifying cellular constituents as perturbed or not perturbed when exposed to drug
12/26/2000US6165478 DNA encoding Chlamydia pneumoniae antigenic polypeptide
12/26/2000US6165476 Fusion proteins with an immunoglobulin hinge region linker